News

Lunit expands AI deployment in military facilities overseas

Lunit is expanding its deployment of an AI imaging solution to South Korean military facilities and troops overseas. 

This comes following the successful pilot deployment of Lunit INSIGHT CXR, its AI-powered chest x-ray analysis software, last year in the army, navy, and air force medical institutions, including the Armed Forces Medical Command and the Armed Forces Capital Hospital. 

The company has been supplying its chest x-ray analysis solution to military-run medical facilities as part of the AI Convergence project of the South Korean Ministry of Science and ICT and the National IT Industry Promotion Agency. 

WHY IT MATTERS

In the fourth year of its participation in the project, Lunit is helping further improve access to diagnostic and treatment services in remote areas where military troops are stationed, such as navy ships. Particularly, it plans to develop a customised AI solution that will be linked with portable x-ray imaging equipment to greatly increase care accessibility.

THE LARGER TREND

Lunit has been participating in the South Korean government’s AI Convergence project since 2020 through its consortium with biotech company Basgen Bio.  

Aside from military facilities, Lunit INSIGHT CXR has also been deployed globally over the past few months. Lunit recently secured partnerships with the Albert Einstein Israelita Hospital in Brazil and with Radlink in Singapore to enhance their chest x-ray analysis capabilities using AI. 

Early this year, Lunit disclosed its plan to open a wholly-owned subsidiary in Europe to assist with its sales and network expansion.

Avatar

admin

About Author

You may also like

News

Senior-focused VR company MyndVR will be covered by New York insurer

VR digital therapeutic company MyndVR announced AgeWell New York’s insurance plans for Medicare and Medicaid patients would cover its senior-focused
News

GoodRx shared health data with Google and Facebook, FTC says

The Federal Trade Commission on Wednesday alleged drug-cost and telehealth platform GoodRx shared consumers’ personal health information with third parties